Skip to main content

Advertisement

Table 1 Clinical characteristics of enrolled individuals

From: Differential expression and predictive value of monocyte scavenger receptor CD163 in populations with different tuberculosis infection statuses

 ATB (n = 67)MPE (n = 21)LTBI (n = 20)HC (n = 21)P value
PTB (n = 39)TBP (n = 28)
Male/Female30/923/516/510/1013/80.0992
Age, median (IQR)44 (28–62)48 (23–66)72 (63–78)53 (40–64)46 (27–65)<0.0001
History of BCG vaccination, n (%)24 (61.5)19 (67.8)11 (52.4)15 (75.0)17 (80.9)0.2913
IGRA+, n (%)///20 (100.0)0 (0)/
Sputum AFB smear or culture positive, n (%)35 (89.7)8 (28.6)0///
1+11 (28.2)7 (25.0)0///
>1+ (2+, 3+, 4+)24 (61.5)1 (3.6)0///
Cavity, n (%)19 (48.7)1 (3.6)0///
M. tb detection in pleural effusion
 Confirmed TBP by pleural biopsy, n (%)/8 (28.6)0///
 AFB smear or culture positive, n (%)/3 (10.7)0///
anti-TB therapy status at enrollment
 Naive, n (%)8 (20.5)23 (82.1)////
 Days on anti-TB, median (IQR)2 (1–7)9 (5–12)////
  1. Variables are shown as medians and IQRs. χ2 test was used for categorical data, and Kruskal-Wallis test was used for continuous data
  2. ATB active tuberculosis, PTB pulmonary tuberculosis, TBP tuberculous pleurisy, MPE malignant pleural effusion, LTBI latent tuberculosis infection, HC healthy control, IQR interquartile range, BCG bacillus Calmette-Guerin, IGRA interferon-γ release assay, AFB acid-fast bacilli